[시장보고서]세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 : 제품 유형별, 애플리케이션별, 지역별

	세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 : 제품 유형별, 애플리케이션별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Dual Specificity Protein Kinase TTK Inhibitors Market, by Product Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
리서치사	Coherent Market Insights
발행일	2021년 12월	상품코드	1045557
페이지 정보	영문	배송안내	2-3일 (영업일 기준)
가격	US $ 4,500 ￦ 5,792,000 PDF (Single User License) US $ 7,000 ￦ 9,011,000 PDF (Multi User License) US $ 10,000 ￦ 12,873,000 PDF (Enterprise User License)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

1인당 의료비의 증가에 의해 만성질환의 치료를 위한 연구개발 활동이 활발해지고 있으며, 이것이 예측 기간 중 시장의 성장을 촉진할 것으로 예상됩니다. 또한 규제기관에 의한 제품 발매의 승인이 증가하고 있는 것도 예측 기간 중 시장 성장의 원동력이 될 것으로 생각되고 있습니다.

세계의 이중특이성 프로테인키나이제 TTK 저해제 시장에 대해 조사했으며, 시장 전망, 시장 역학, 시장 분석, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

Protein kinases play an important role in the catalytic activity and signaling functional transduction of critical cellular processes. TTK, also called monopolar spindle 1 (Mps1), is a dual specificity kinase that causes the phosphorylation of both tyrosine and serine/threonine residues. It is one of the spindle assembly checkpoint (SAC) that facilitates the alignment of chromosomes on the metaphase plate in mitosis which is associated with the progression of the cell cycle. TTK is essential for the right alignment of all chromosomes, and subsequently, correct attachment to the mitotic spindle. Targeting this kinase may effectively block chromosome segregation during mitosis, and it could be a great invention for cancer therapy.

Market Dynamics

The increased per capita healthcare spending has enhanced research and development activities for the treatment of chronic diseases, which is expected to drive the global dual specificity protein kinase TTK inhibitors market growth over the forecast period. According to the World Bank estimates in 2019, the per capita healthcare expenditure increased significantly in Latin America. The healthcare expenditure in Latin America was around US$ 638 Mn in 2016, which increased to US$ 666 Mn by 2018.

Increasing approvals for product launches by the regulatory bodies is also expected to drive the market growth over the forecast period. For instance, in January 2019, Dacomitinib, a selective and irreversible inhibitor of EGFR by Pfizer Inc., a leading research-based biopharmaceutical company, received approval from the Ministry of Health, Labour and Welfare of Japan for the treatment of EGFR mutation-positive inoperable or recurrent non-small cell lung cancer (NSCLC).

Key features of the study:

This report provides in-depth analysis of the global dual specificity protein kinase TTK inhibitors market, market size (US$ Mn), and the compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dual specificity protein kinase TTK inhibitors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Boston Pharmaceuticals, Nerviano Medical Sciences S.R.L (Part of NMS group), and Servier Laboratories
Insights from this report would allow marketers and the management authorities of companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global dual specificity protein kinase TTK inhibitors market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dual specificity protein kinase TTK inhibitors market

Detailed Segmentation:

Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Product Type:
- BAY 1217389
- BOS-172722
- CFI-402257
- S 81694
- Others
Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Application:
- Non-hematologic Malignancies
- Breast Cancer
- Prostate Cancer
- Pancreatic Ductal Adenocarcinoma
- Others
Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Region:
- North America
  - Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
  - Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
  - By Country
  - U.S.
  - Canada
- Latin America
  - Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
  - Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
  - Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
  - Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
  - Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - Product Type
  - BAY 1217389
  - BOS-172722
  - CFI-402257
  - S 81694
  - Others
  - Application
  - Non-hematologic Malignancies
  - Breast Cancer
  - Prostate Cancer
  - Pancreatic Ductal Adenocarcinoma
  - Others
  - By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Bayer AG
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc.
- Boston Pharmaceuticals
- Nerviano Medical Sciences S.R.L (Part of NMS group)
- Servier Laboratories.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Pipeline Analysis
Mergers and Acquisitions
Regulatory & Reimbursement Scenario

4. Global Dual Specificity Protein Kinase TTK Inhibitors Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact on Healthcare Market
New Developments
Impact on Clinical Trials

5. Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Product Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
BAY 1217389
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
BOS-172722
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
CFI-402257
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
S 81694
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Application, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 - 2028
- Segment Trends
Non-hematologic Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Pancreatic Ductal Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Dual Specificity Protein Kinase TTK Inhibitors Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2028
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boston Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nerviano Medical Sciences S.R.L (Part of NMS group)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Servier Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

F A Q

세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 : 제품 유형별, 애플리케이션별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Dual Specificity Protein Kinase TTK Inhibitors Market, by Product Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

목차

제1장 조사 목적·전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 : 제품 유형별(100만 달러)(2017-2028년)

제6장 세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 : 애플리케이션별(100만 달러)(2017-2028년)

제7장 세계의 이중특이성 프로테인키나이제 TTK 저해제 시장 : 지역별(100만 달러)(2017-2028년)

제8장 경쟁 구도

제9장 섹션